Fluidigm's Polaris

Fluidigm said this week that it will provide attendees of the Advances in Genome Biology and Technology meeting a first look at the firm's new Polaris single-cell research system. Polaris integrates cell selection, isolation, dose, culture, and molecular preparation into a single workflow. According to the firm, it will enable researchers to directly correlate gene expression with environmental conditions and phenotypic information. Fluidigm plans to begin shipping the new system mid-year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.